Emerging Nano-Carrier Strategies for Brain Tumor Drug Delivery and Considerations for Clinical Translation

David J. Lundy, Helen Nguyễn, Patrick C. H. Hsieh

Open source

DOI
10.3390/pharmaceutics13081193
Published
2021-08-03
Container
Pharmaceutics
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/pharmaceutics13081193,
  title = {Emerging Nano-Carrier Strategies for Brain Tumor Drug Delivery and Considerations for Clinical Translation},
  author = {David J. Lundy and Helen Nguyễn and Patrick C. H. Hsieh},
  year = {2021},
  journal = {Pharmaceutics},
  doi = {10.3390/pharmaceutics13081193},
  url = {https://doi.org/10.3390/pharmaceutics13081193}
}

RIS

TY  - JOUR
TI  - Emerging Nano-Carrier Strategies for Brain Tumor Drug Delivery and Considerations for Clinical Translation
AU  - David J. Lundy
AU  - Helen Nguyễn
AU  - Patrick C. H. Hsieh
PY  - 2021
JO  - Pharmaceutics
DO  - 10.3390/pharmaceutics13081193
UR  - https://doi.org/10.3390/pharmaceutics13081193
ER  - 

APA

Lundy, D. J., Nguyễn, H., & Hsieh, P. C. H. (2021). Emerging Nano-Carrier Strategies for Brain Tumor Drug Delivery and Considerations for Clinical Translation. Pharmaceutics. https://doi.org/10.3390/pharmaceutics13081193

Source records